Interview with Marisa Sanvito, Senior Director, Quintiles Brazil
Many international CROs entered Brazil in the past few years, whereas Quintiles made its first move in Brazil in 1996. What was the strategic decision behind entering Brazil at that…
Address: Praça São Marcos, 624 05455-050 – São Paulo – SP,Brazil
Tel: 0800-772-4656
Web: http://www.ferring.com.br/
In 1950 in Malmö, Sweden, Dr. Frederik Paulsen founded Laboratoriet Nordiska hormone, which in 1954 changed its name to Ferring.
A world leader in peptide hormones, Ferring was a pioneer in developing and selling pharmaceutical products based on natural hormones, the pituitary-produced peptide. Dr. Paulsen was convinced that these new compounds could be used to supplement deficiencies and abnormalities, making an invaluable role in the treatment of various diseases.
Five decades later, Dr. Paulsen’s predictions have proven inaccurate. Today, the peptides are widely used in various treatments of Ferring.
Over the past years Ferring has expanded its activities beyond its European base and now have subsidiaries operating in over 40 countries, including Brazil, which is the company’s fastest-growing subsidiary. Its annual turnover is 700 million and has over 3,000 employees. Over the next three to five years, the group aims to triple sales in Brazil.
Propess, BioGaia, DDAVP, Choragon, Bravelle, FemLab, Menogon
Many international CROs entered Brazil in the past few years, whereas Quintiles made its first move in Brazil in 1996. What was the strategic decision behind entering Brazil at that…
PGS is a member of ABRACRO, but is in a unique position as both a CRO and a service provider to CROs and pharmaceutical companies. Can you elaborate on the…
The government recently released the ‘BrasilMaior’ plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
The government recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
We met recently with Minister Pimentel when he launched his BrasilMaior plan, whose slogan was “Innovate to Compete. Compete to Grow.” If you had to make a recommendation to increase…
When we last interviewed you in 2007, you said, “The generics business is a very exciting one,” but you “regret[ted] that the Government is not doing enough work to promote…
As I was doing research on your company, GC-2, I was unable to find a lot of information since it is a rather new company. Could you bring me up…
In a past interview, you said that Ipsen is different than the “Big Pharmas” who have entered Brazil by acquisition. You’ve taken a different tack since arriving as one of…
There is little publicly available information on your personal history and the founding of Meizler. Can you share that story for our readers? Everybody has a story – unless they’re…
Diabetes affects an estimated 6 million Brazilians, a figure which is expected to double by 2025, in line with many other developing nations. Like many other “rich-country” diseases, there is…
An important topic in Brazil is access to drugs. In recent interviews we have spoken about a third of MS patients being treated, or 10% of hypertensives having their condition…
Yesterday the Ministry of Health released an article stating that chronic diseases now account for 70% of all deaths in Brazil, and welcoming suggestions for the national plan against chronic…
See our Cookie Privacy Policy Here